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Abstract
 
To dissect the influence of CD21/CD35 and Fc
 
 
 
RIIB in antigen retention and humoral
memory, we used an adoptive transfer model in which antigen-primed B and T lymphocytes
were given to sublethally irradiated wild-type mice or mice deficient in CD21/CD35 (Cr2
 
 
 
/
 
 
 
)
or Fc
 
 
 
RIIB receptors (Fc
 
 
 
RIIB
 
 
 
/
 
 
 
). Cr2
 
 
 
/
 
  
 
chimeras showed impaired memory as character-
ized by a decrease in antibody titer, reduced frequency of antibody secreting cells, an absence
of affinity maturation, and significantly reduced recall response. The impaired memory in
Cr2
 
 
 
/
 
  
 
chimeras corresponded with the reduced frequency of antigen-specific memory B cells.
Interestingly, Fc
 
 
 
RIIB
 
 
 
/
 
  
 
chimeras showed a differential phenotype with impaired splenic but
normal bone marrow responses. These data suggest that CD21/CD35 on stroma, including
follicular dendritic cells, is critical to the maintenance of long-term B lymphocyte memory.
Key words: B lymphocytes • memory • complement receptors • Fc
 
 
 
RIIB • follicular 
dendritic cells
 
Introduction
 
Long-term humoral memory is defined as the ability to
generate a more effective antibody response after encounter
with the original stimulating T-dependent antigen. In hu-
mans, humoral memory can persist for decades after initial
antigen exposure as evidenced by the continued presence
of antigen-specific immunoglobulin (1). Because serum
immunoglobulins have half-lives for 1–3 wk (–4), the B
lymphocyte compartment must continually produce spe-
cific immunoglobulin for long-term protection.
Effective recall responses to recurrent antigen exposure
are postulated to require both preexisting, circulating anti-
gen-specific antibody and memory B lymphocytes (5). An-
tibody-secreting cells (ASCs)
 
* 
 
generate antigen-specific se-
rum immunoglobulin that neutralizes harmful antigens and
promotes efficient antigen trapping important for recall re-
sponses. Memory B lymphocytes quickly respond to cog-
nate antigen, giving rise to new ASCs producing higher
affinity immunoglobulins. Traditional models of humoral
memory explain antibody persistence by continued differ-
entiation of memory B lymphocytes into terminally differ-
entiated ASCs (6). These models are called into question by
the recent observation that some ASCs are long-lived, re-
siding predominantly in the bone marrow (BM) and spleen
(7, 8). Therefore, antigen-specific serum immunoglobulin
titers could be maintained by these long-lived ASCs in the
absence of continued differentiation of memory B lympho-
cytes. However, several classic studies suggest that contin-
ued differentiation of memory B lymphocytes is critical for
optimal memory. Not only do serum immunoglobulin lev-
els decrease more dramatically in the absence of antigen (9,
10), but the average affinity of serum immunoglobulin in-
creases markedly with time after initial antigen encounter
(i.e., affinity maturation; 11, 12), suggesting that the selec-
tion of high affinity B lymphocytes is an ongoing process.
Therefore, despite the long-lived nature of some ASCs,
continued differentiation of memory B lymphocytes likely
plays a major role in humoral memory. Also implicit in
these classic observations is that antigen is required for affin-
ity maturation and for maintaining antibody titers. There-
fore, understanding how antigen is retained long-term is
paramount to understanding how affinity maturation and
antibody titers continue after antigen exposure.
Memory B lymphocytes and long-lived ASCs are gener-
ated as end products of germinal center (GC) reactions
(1, 13). Antigen sequestered on follicular dendritic cells
(FDCs) within GC light zones provides the substrate for se-
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lection of high affinity B lymphocytes into the memory
compartment. FDCs harbor antigen over a long term, sug-
gesting that these cells have a critical role in humoral mem-
ory. Consistent with this idea is the recent observation that
LT
 
 
 
R
 
null 
 
mice, whose principally defined mutation is a lack
of detectable FDCs and GCs, are incapable of maintaining
high titer serum immunoglobulin levels (14). Despite the
implied role for FDCs in sustaining humoral memory by
making antigen available long-term, the mechanism of an-
tigen retention is unknown.
Two classes of receptor molecules capable of trapping
antigen on FDCs are complement receptors, i.e., CD21/
CD35 and Fc
 
 
 
RIIB receptors. CD21/CD35 have a major
role in generating the memory B lymphocyte compart-
ment. The depletion of complement component C3 before
immunization led to diminished immune complexes on
FDC surfaces, suggesting that C3-tagged antigen and/or
immune complexes are trapped via CD21/CD35 (15). In
addition, mice deficient in complement components C3
and C4 or receptors CD21/CD35 have reduced abilities to
trap a wide array of both T-independent and T-dependent
antigens, leading to markedly impaired short-term humoral
responses (16–19). Short-term humoral responses appear
less dependent on FDC-derived CD21/CD35 because chi-
meric mice (i.e., WT BM into Cr2
 
 
 
/
 
  
 
recipient mice) have
normal to slightly reduced antibody responses (20). The
role of CD21/CD35 in antigen deposition for long-term,
i.e., memory responses, is less defined, although chimeric
mice lacking CD21/CD35 on FDCs, but not on B lym-
phocytes, generate reduced antibody titers after secondary
challenge (20, 21). Unlike CD21/CD35, Fc
 
 
 
RIIB is not
constitutive on the surface of FDCs and instead is inducibly
up-regulated after immunization (22). Fc
 
 
 
RIIB-deficient
mice are hyperresponsive (23), although this likely results
from diminished regulatory signaling on B lymphocytes
rather than any perturbation in antigen deposition (24). Be-
cause Fc
 
 
 
RIIB is up-regulated on FDCs after immuniza-
tion and because persisting antibody titers are considered
important for immune complex deposition, it was sug-
gested that Fc
 
 
 
RIIB might be critical for trapping IgG–
antigen immune complexes required for maintaining hu-
moral memory as well as for recall responses.
In this study, we investigate the influence of antigen re-
tention on antibody titers and affinity maturation. We find
that complement receptors CD21/CD35 on recipient
stroma are critical in ensuring normal ASC and memory B
lymphocyte frequency, high antibody titers, and continued
affinity maturation. Moreover, FDC expression of CD21/
CD35 is critical for effective recall responses. In contrast,
antibody persistence and the recall response are less depen-
dent on stromal cell expression of Fc
 
 
 
RIIB receptors, al-
though frequencies of splenic ASCs and memory B lym-
phocytes are reduced relative to WT chimeras.
 
Materials and Methods
 
Mice.
 
Mice were housed at Harvard Medical School in a
specific pathogen-free facility. C57BL/6 mice (Jackson Immu-
 
noResearch Laboratories) and C57BL/6-CD45.1 congenic mice
(National Cancer Institute) were used as sources of memory T
and B lymphocytes. Recipient mice included the following ge-
notypes: C57BL/6, Cr2
 
 
 
/
 
  
 
backcrossed 5 and 10 generations to
C57BL/6, and Fc
 
 
 
RIIB
 
 
 
/
 
  
 
mice backcrossed 3 generations on a
C57BL/6 background (Taconic). Notably, no experimental dif-
ferences were found in recipient mice with different degrees of
C57BL/6 backcrossing.
 
Adoptive Transfer Protocol and Immunization Protocol.
 
4-hydroxy-
3-nitrophenyl (NP)-specific memory B lymphocytes were gener-
ated using C57BL/6-CD45.1 congenic mice. First immunized
with 50 
 
 
 
g 10% alum-precipitated (Sigma-Aldrich) NP
 
5
 
-BSA
(Biosearch Technologies) intraperitoneally, these mice were then
boosted with the same antigen dose after 3 wk. Splenic mononu-
clear cells were isolated by ficoll-hypaque density centrifugation.
To enrich for B lymphocytes, splenic mononuclear cells from
NP-BSA–primed CD45.1 congenic mice were incubated with an
antibody cocktail consisting of rat IgG anti–mouse CD4, CD8,
CD11b/CD18, and IgD (Caltag and Amersham Biosciences) at
concentrations of 10
 
7 
 
cells/ml and 1 
 
 
 
g/ml/antibody. Anti–
mouse IgD was added to the cocktail to restrict the recovery of
predominating naive B lymphocytes. Cells were then panned
twice on Petri dishes coated with goat anti–rat IgG (mouse ad-
sorbed; Southern Biotechnologies) for 1 h at 4
 
 
 
C. B lymphocyte
purity ranged from 70–80% with 
 
 
 
10% T lymphocyte and
 
 
 
10% macrophage contamination (unpublished data). 
 
 
 
10% of
adoptively transferred B lymphocytes were NP specific as deter-
mined by FACS
 
®
 
. The NP-specific memory response was
IgG1
 
 
 
 
 
  
 
as determined by ELISA and BIAcore.
Keyhole limpet hemocyanin (KLH)-specific T lymphocytes
were generated from C57BL/6 mice immunized intraperito-
neally with 50 
 
 
 
g alum-precipitated KLH as described above.
Similarly, splenic mononuclear cells were enriched for T lym-
phocytes by incubation with an antibody cocktail consisting of rat
IgG anti–mouse B220, CD19, CD11b/CD18, and IgD. Spleno-
cytes were then panned as described above. T lymphocyte purity
was 50–70% in the transferred population with 10–30% B lym-
phocyte contamination and 
 
 
 
10% macrophage contamination.
Single cell suspensions of 10
 
7 
 
B and 5 
 
  
 
10
 
6 
 
T lymphocytes
were adoptively transferred with 50 
 
 
 
g soluble NP
 
5
 
-KLH intra-
venously into sublethally irradiated (650 RAD, Cs source)
MHC-identical recipient mice (CD45.2). Irradiated control
mice were given antigen but no memory B or T lymphocytes
after irradiation. 3 or 16 wk after adoptive transfer, recipient
and control mice were challenged intravenously with 50 
 
 
 
g sol-
uble NP
 
5
 
-KLH and 1 wk after mice were killed, tissues were
isolated to measure recall responses. Recipient and control mice
were bled periodically throughout the 16-wk rest period. Se-
rum was analyzed by ELISA for specific antibody production to
NP (see below).
For secondary adoptive transfers, single cell suspensions of 10
 
7
 
B lymphocytes from the primary chimeras were given intrave-
nously with 5 
 
  
 
10
 
6 
 
T lymphocytes from KLH-primed mice and
50 
 
 
 
g NP
 
5
 
-KLH were given to sublethally irradiated WT or
Cr2
 
 
 
/
 
  
 
recipients. These mice were analyzed 3 wk later.
 
Anti-NP Response and Affinity Measurements by ELISA.
 
Serum
was collected from individual mice and NP-specific antibody ti-
ters were determined by sandwich ELISA. 96-well plates (Immu-
lon 1B) were coated with 5 
 
 
 
g/well NP
 
5
 
-BSA or NP
 
15
 
-BSA.
Plates were blocked with the addition of 5% dry milk (Carna-
tion
 
®
 
) in PBS (Blotto). NP-specific IgG serum antibody in serially
diluted samples was detected by alkaline phosphatase–conjugated
goat anti–mouse IgG (Sigma-Aldrich). Between incubations, 
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plates were washed with PBS containing 0.1% Tween. Color was
developed using p-nitrophenyl phosphate (Sigma-Aldrich) as sub-
strate and absorbance was measured at 405 nm using Softmax
software package. Antibody titer was determined as the reciprocal
of the greatest dilution whose absorbance remained above back-
ground. For relative affinity measurements, the ratio of titers to
NP
 
5
 
-BSA and NP
 
15
 
-BSA was calculated for individual mice using
OD
 
405 
 
in the linear ranges of the assays as previously described
(25).
 
Relative Serum Antibody Affinity to NP Determined by BIAcore.
 
A BIAcore 2000™
 
 
 
was used to study the kinetics of anti-NP se-
rum IgG binding to NP. Standard amine coupling was used to
immobilize goat anti–mouse IgG Fc
 
  
 
(Jackson ImmunoResearch
Laboratories) diluted to 30 
 
 
 
g/ml in 10 mM acetic acid buffer,
pH 4.0, to a CM5 sensor chip (Biosensor AB; Amersham Bio-
sciences). A second flow cell on the chip was prepared using the
same procedure, without goat anti–mouse IgG Fc
 
 
 
, to subtract
out significant nonspecific responses. Experiments were per-
formed at 25
 
 
 
C with a 10-
 
 
 
l/minute flow rate. Serum samples
diluted 1:1,000 in HBS (BIAcore) containing 1% BSA were in-
jected over the chip. Captured serum IgG was tested for antigen-
binding kinetics by injection with NP
 
5
 
-BSA. Apparent kinetic
rate constants (k
 
d 
 
and k
 
a
 
) for NP
 
5 
 
binding to serum IgG antibodies
were estimated using nonlinear curve fitting with BIAevaluation
3.1 software (BIAcore). Equilibrium dissociation constants (K
 
D
 
)
were calculated as k
 
d
 
/k
 
a
 
. All values were determined by first nor-
malizing to the amount of IgG bound to the chip.
 
Enzyme-linked Immunospot Assay for NP-specific ASCs.
 
Frequen-
cies of NP-specific ASCs were quantitated as previously described
(26). In brief, 24-well polystyrene plates (Costar) were coated
with NP
 
5
 
-BSA. After extensive washing, plates were blocked
with 1% BSA in PBS for 2 h. Serially diluted splenic mononu-
clear cells or BM cells (10
 
6 
 
to 10
 
3 
 
cells/well) were added in
DMEM media with 2% fetal bovine serum and incubated over-
night at 37
 
 
 
C. Each dilution of cells was assayed in duplicate.
Plates were then washed with PBS containing 0.1% Tween and
incubated with alkaline phosphatase–conjugated goat anti–mouse
IgG antibody (Sigma-Aldrich). Plates were developed using
5-bromo-4-chloro-3-indolyl phosphate at 1 mg/ml in 0.6% aga-
rose to produce blue-colored spots identifying NP-specific ASCs.
Spots were counted to determine ASC frequency. As controls,
each sample was also plated in wells coated with BSA or KLH.
Few BSA-specific ASCs were detected in the BM or spleen and
 
 
 
100 KLH-specific ASCs were observed per recipient spleen
(unpublished data).
 
Immunohistology and Antigen Deposition.
 
Chimeric mice were
given 50 
 
 
 
g soluble NP
 
5
 
-BSA biotin intravenously 16 wk after
adoptive transfer. Spleens were isolated 16–18 h after injection
and prepared for immunohistology as previously described (27).
5-
 
 
 
m thick sections were examined for antigen retention within
splenic compartments using streptavidin-coupled TRITC (Sigma-
Aldrich). Peanut agglutinin (PNA; E-Y Laboratories) coupled to
FITC was used to identify GCs and B lymphocyte zones were
delineated with Cy5-coupled anti-IgM antibody (BD Bio-
sciences). Staining was visualized by confocal microscopy (Radi-
ance 2000; Bio-Rad Laboratories).
 
FACS
 
® 
 
Analysis and Identification of NP-specific Memory B
Cells.
 
Single cell suspensions of splenocytes and BM cells were
incubated on ice with rat anti–mouse CD16/CD32 (2.4G2; BD
Biosciences). Cells were then treated with a cocktail of NP cou-
pled to allophycocyanin (Molecular Probes), FITC-conjugated
goat anti–mouse Ig
 
  
 
(Southern Biotechnology Associates, Inc.),
PE-conjugated rat anti–mouse CD19 (1D3; BD Biosciences),
 
and biotinylated rat anti–mouse CD45.1 (A20; BD Biosciences).
After washing, cells were incubated on ice with streptavidin-
PerCP (BD Biosciences). Cells were analyzed with a FACSCali-
bur
 
® 
 
(Becton Dickinson). CD19
 
 
 
CD45.1
 
 
 
 
 
 
 
NP
 
  
 
cells within
the lymphocyte gate were considered memory B lymphocytes.
These cells were negative for cell surface expression of CD138,
IgM, CD3, and CD11b.
 
Statistical Analysis.
 
All statistical comparisons reported used
the standard two-tailed 
 
t 
 
test assuming unequal variance.
 
Results
 
The mechanism of long-term antigen retention partici-
pating in humoral memory was examined using a hapten
carrier adoptive transfer model. A similar adoptive transfer
system was used previously in rats to demonstrate that per-
sisting antibody titers and recall responses depended on the
presence of antigen (9). This approach was used to create
chimeric mice with differential expression of complement
and Fc
 
 
 
RIIB receptors on FDC stroma and B lymphocytes.
To test the importance of CD21/CD35 and Fc
 
 
 
RIIB in
harboring antigen for long-term memory, NP-specific
memory B lymphocytes, KLH-primed T lymphocytes, and
antigen (NP-KLH) were transferred into sublethally irradi-
ated recipient mice deficient in CD21/CD35 (Cr2
 
 
 
/
 
 
 
) or
Fc
 
 
 
RIIB (Fc
 
 
 
RIIB
 
 
 
/
 
 
 
), as well as WT controls. Thus,
chimeric mice have normal complement and Fc
 
 
 
RIIB-suf-
ficient B lymphocytes but their stromal cells and radioresis-
tant myeloid cells are receptor deficient. To control for en-
dogenous responses, parallel sets of recipient mice were
treated identically except that they did not receive memory
lymphocytes. Finally, to identify transferred memory B
lymphocytes C57BL/6 mice congenic for the CD45.1 al-
lotypic marker were used as donors, whereas recipient mice
expressed CD45.2 exclusively.
 
Short-Term Responses. Short-term antibody responses
were examined in the presence or absence of CD21/CD35
or Fc RIIB. All groups of chimeric mice had comparable
anti-NP titers 3 wk after lymphocyte transfer with mean ti-
ters ranging from 16.7   103 to 22.7   103 (Table I). NP
titers in WT chimeras deprived of antigen were substan-
tially reduced. When WT and Cr2 /  chimeric mice were
challenged with NP5-KLH 3 wk after the initial transfer of
antigen and memory lymphocytes, specific IgG titers were
again comparable between WT and Cr2 /  recipient mice
(unpublished data). These data suggest that the adoptively
transferred memory B lymphocytes were generating equiv-
alent short-term antibody responses irrespective of stromal
expression of CD21/CD35.
Long-Term Antibody Persistence. To measure long-term
antibody responses, changes in serum anti-NP titers were
monitored over 16 wk for each chimeric mouse (Table I).
WT mice receiving adoptively transferred cells in the ab-
sence of antigen generated two to three times less antibody
compared with WT chimeras receiving antigen, demon-
strating that optimal responses are antigen dependent. 6–8
wk after adoptive transfer, antibody titers in WT and
Fc RIIB /  chimeras dropped by  25% of the initial titer,1192 B Lymphocyte Memory Dependency on Complement Receptors
whereas anti-NP titers fell  50% in chimeric mice lacking
CD21/CD35   stroma. WT and Fc RIIB /   chimeric
mice maintained significantly higher titers compared with
Cr2 /  chimeras until the end of the experimental protocol
(P   0.015; Table I). Importantly, anti-NP titers were neg-
ligible in irradiated control mice, suggesting that donor B
lymphocytes were the principle source of responding B
lymphocytes in experimental mice (Table I).
The significant decrease in antibody titers in Cr2 /  chi-
meric mice suggested that the frequency and/or number of
plasma cells was impaired in the absence of CD21/CD35.
To examine this possibility, BM and spleens from recipient
mice 16 wk after transfer were analyzed for NP-specific
ASCs by ELISPOT. The BM of WT and Fc RIIB /  chi-
meric mice had similar frequencies of NP-specific ASCs
(13.4   3.2 and 11.6   3.7 ASCs/106 BM cells, respec-
tively; Fig. 1 a). In contrast, the BM of Cr2 /  chimeras
had two- to threefold fewer NP-specific ASCs (5.6  1.1
ASCs/106 BM cells, P   0.035). Similar reductions were
found in splenic NP-specific ASCs of mice lacking CD21/
CD35 (25.1  4.4 vs. 9.4   1.6 ASCs/106 splenocytes in
WT and Cr2 /  chimeras, P   0.004; Fig. 1 b). Unlike
the frequency of NP-specific ASCs observed in BM,
Fc RIIB /  chimeric mice had reduced frequencies of
ASCs in the spleen when compared with WT chimeras
(10.9   3.1/106 splenocytes, P   0.016). In both the BM
and spleen, the ASCs were likely donor cell derived be-
cause irradiated control mice from each genotype tested
failed to produce NP-specific ASCs (all recipient genotype
controls are pooled in the bar shown in Fig. 1). As ex-
pected, negligible numbers of ASCs were observed in the
BM and spleen of WT chimeric mice deprived of antigen.
Therefore, the presence of CD21/CD35 on recipient
stroma is required for optimal production and/or suste-
nance of plasma cells.
One explanation for reduced ASCs in Cr2 /  chimeras
is that ASCs are short-lived and require replacement by
antigen-dependent precursors (28). To determine if there
was a reduction in memory B lymphocytes in the Cr2 / 
chimeras, frequencies of CD45.1  (donor-derived) NP-
binding    (CD138 ) B lymphocytes were assessed 16 wk
after transfer. CD138  staining was used to distinguish
memory B lymphocytes from ASCs. Based on FACS®
analysis, a significant reduction in memory B lymphocytes
was observed in the spleens of receptor-deficient chimeras,
i.e., 310   55 vs. 125   25, 129   29, and 63   18 per
106 splenocytes for WT, Cr2 / , Fc RIIB / , and WT
no antigen, respectively (Fig. 2, a and c). Similar reduc-
tions in donor-derived NP-specific memory B lympho-
cytes were found in BM, although only chimeras lacking
CD21/CD35  stroma and WT no antigen chimeras had
significant reductions relative to WT chimeras (Fig. 2 b).
Therefore, reduced ASC frequency and serum antibody ti-
ters in Cr2 /  chimeras might be caused by reduced fre-
quencies of memory B lymphocytes.
Another potential contributing factor for reduced fre-
quency of NP-specific ASCs and memory B lymphocytes
Table I. Persistence of NP Titers after Adoptive Transfer of Memory B Lymphocytes and During the Recall Response
Chimera Time after transfer of NP-specific memory B lymphocytes (NP-specific IgG titers,  103)
2–3 wk 6–8 wk 10–12 wk 16 wk 17 wk
WT (n   34) 22.7   3.8 19.7   3.8 10.4   1.9 6.4   1.2 67.2   19.1
Cr2    (n   31) 16.7   2.7 9.5   1.7* 5.8   1.1* 2.9   0.7* 6.4   1.8*
Fc RIIB    (n   32) 22.3   5.2 15.4   4.4 7.3   1.6 4.6   1.5 38.4   14.9
WT, no antigen (n   8) 8.9   3.4* 7.7   3.0* 5.1   2.3* 2.1   0.7* 1.6   2.1*
Irradiated controls (n   41)  1.6*  1.6*  1.6*  1.6*  1.6*
Numbers represent mean anti-NP IgG titers ( 103)   SEM at the indicated time points after adoptive transfer of NP-specific memory B lymphocytes.
*, statistically significant differences upon comparison to WT. Results are pooled from six independent experiments.
Figure 1. Frequency of NP-specific ASCs in chimeric mice 16 wk af-
ter receiving memory B lymphocytes. Recipient BM (a and c) and spleen
(b and d) before (a and b) or 1 wk after antigen challenge intravenously
with 50  g NP5-KLH (c and d) were analyzed by ELISPOT for IgG-
secreting plasma cells specific for NP. Data are represented as means  
SEM (a and b shows three independent experiments and c and d shows
four independent experiments). n   number of mice in each group. *,
statistically significant differences upon comparisons to WT chimeras
(P   0.035 BM and P   0.02 spleen).1193 Barrington et al.
in the absence of CD21/CD35 on recipient stroma is a
general reduction in chimerism relative to WT recipients.
The degree of chimerism was determined by comparing
the ratio of donor B lymphocytes (CD45.1 CD19 ) ver-
sus total B lymphocytes (total CD19 ). On average, the
frequency of donor B lymphocytes was slightly greater in
WT mice compared with Cr2 /  mice, although the dif-
ference was not significant (35.8   4.75%, 32.6   4.1%,
and 23.8    3.3% in the spleens of WT, Cr2 / , and
Fc RIIB /  chimeras, respectively). Therefore, the degree
of chimerism does not explain the differences in frequen-
cies of NP-specific ASCs and memory B lymphocytes be-
tween recipient groups.
Affinity Maturation. Given the importance of antigen in
affinity maturation and the implication that CD21/CD35-
bearing stroma is important for long-term antigen reten-
tion, it was proposed that affinity maturation might also be
impaired in the absence of CD21/CD35. To estimate rela-
tive serum affinity, two approaches were taken. The first
approach used ELISA to determine the ratio of antibody ti-
ters binding low (NP5) to highly (NP15) haptenated BSA.
No significant differences in the ratio of NP5/NP15 titers
were detected between the recipient groups 3 wk after the
transfer of memory B lymphocytes (Fig. 3). In WT chime-
ras, the relative serum affinity increased modestly with time
(from 52   5% at 3 wk after transfer to 70   7% at 16 wk,
P   0.03). Relative serum affinities did not change signifi-
cantly with time in Cr2 /  chimeras (53   4% to 48   6%,
from 3 to 16 wk, respectively). The most significant
changes in relative serum affinities were observed in
Fc RIIB /  chimeras (60   6% to 84   6%, P   0.006).
To confirm that relative serum affinities in Fc RIIB / 
chimeras increase markedly with time after the transfer of
memory B lymphocytes, surface plasmon resonance was
used to examine the real-time kinetics of anti-NP serum
IgG binding to NP-BSA. Real-time measurements ob-
tained by this technique allow an estimate of affinity based
on relative on/off rates (KD   kd/ka). WT chimeras dem-
onstrated modest yet incremental increases in affinity
whereas Cr2 /  chimeras failed to show statistically signif-
icant changes (for WT,  KD of 1.5   10 8 over 16 wk af-
ter cell transfer, P   0.03; Table II). In contrast to Cr2 / ,
Fc RIIB /  chimeras demonstrated significant increases
in affinity constants with time after cell transfer ( KD of
Figure 2. Frequency of donor-derived, NP-specific memory B lym-
phocytes in chimeric mice 16 wk after adoptive transfer. (a) Representative
scheme to identify antigen-specific, donor-derived memory B lympho-
cytes by FACS®. Frequency of NP-binding CD45.1 Ig   B lymphocytes
(CD19 ) was determined from mouse BM (b and c) and spleen (d and e)
before (b and d) or 1 wk after antigen challenge intravenously with 50  g
NP-KLH (c and e). Cells were also confirmed as CD3 , IgM , CD138 ,
and CD11b . Data are represented as means   SEM of three independent
experiments. n   number of mice in each group. *, statistically significant
differences upon comparisons to WT chimeras (P   0.01 BM and spleen
prechallenge and P   0.04 after challenge).
Table II. Changes in Relative Serum Affinity after Adoptive 
Transfer of Memory B Lymphocytes
Mean  KD (BIAcore)
Chimera 1–12 wk 14–16 wk
WT 1.6   10 8* 1.5   10 8*
Cr2    0.8   10 8 1.4   10 8
Fc RIIB    0.2   10 8
4.8   10 8*
Mean changes in relative affinity ( KD; left side of table) were
determined by calculating equilibrium dissociation constants (KD) for
each time point serum sample, followed by subtraction of starting KD
values 2–3 wk after cell transfer (n   20 for WT, 11 each for Cr2 /  and
Fc RIIB /  chimeras). Results are summarized from two independent
experiments. *, statistically significant differences upon comparison to
mean 2–3-wk time point values (P   0.03 for WT chimeras and P  
0.003 for Fc RIIB /  chimeras).
Figure 3. Changes in relative serum affinity with time after antigen ex-
posure. Sera collected from chimeric mice were titrated in ELISA for the
amount of high affinity (NP5-BSA) and the amount of total (NP15-BSA)
IgG. The ratio of NP5:NP15 titers is expressed as mean ratios   SEM and
are compiled from four independent experiments.  , WT chimeras (n  
34);  , Cr2 /  chimeras (n   31);  , Fc RIIB /  chimeras (n   32); *,
statistically significant differences. Statistical comparisons were made to
the 2–3-wk time point for each group (P   0.01).1194 B Lymphocyte Memory Dependency on Complement Receptors
4.8   10 8 over 16 wk after transfer, P   0.003). There-
fore, the absence of Fc RIIB-bearing stroma potentiates
affinity maturation.
Recall Responses. By definition, memory responses are
faster and more robust than primary responses. The contri-
bution of CD21/CD35 and Fc RIIB receptors on recall
responses was tested in the current model by challenging
chimeric mice intravenously with soluble NP5-KLH 4 mo
after adoptive transfer. 1 wk later, mice were analyzed for
antibody titers and frequency of ASCs and memory B lym-
phocytes. Anti-NP titers increased approximately 10-fold
in WT and Fc RIIB /  chimeric mice after challenge
(mean prechallenge to postchallenge titers   6.4   103 to
67.2     103 for WT and 4.6    103 to 38.4    103 for
Fc RIIB /  chimeras; Table I). By contrast, the mean
anti-NP titer increased approximately twofold in Cr2 / 
chimeras after antigen challenge and was approximately 10-
fold less than that observed in WT chimeras (from 2.9  
103 to 6.4   103; Table I). Therefore, the recall response of
Cr2 /  chimeric mice was substantially reduced compared
with WT and Fc RIIB /  chimeras.
To determine whether antibody titers correlated with
the frequency of effector cells, NP-specific ASCs from the
BM and spleen from all groups of mice were measured by
ELISPOT after antigen challenge. The frequency of NP-
specific ASCs increased  10-fold in the BM and 100-fold
in the spleen in all groups (compare Fig. 1, a to c and b to
d). WT and Fc RIIB /  chimeras produced similar fre-
quencies of NP-specific BM ASCs, consistent with similar
antibody titers generated as part of the memory response
(Fig. 1 c). In contrast, the relative frequency of NP-specific
ASCs was reduced two- to threefold in the spleen and BM
of Cr2 /  chimeras compared with WT chimeras. This
suggested that reductions in memory B lymphocyte fre-
quency and/or reduced antigen localization via CD21/
CD35 contributed to reduced recall responsiveness. De-
spite a near 10-fold increase in antibody titer, Fc RIIB / 
chimeras had significantly reduced frequency of splenic
ASCs compared with WT chimeras.
To assess whether the renewed production of NP-spe-
cific memory B lymphocytes was affected in the absence of
CD21/CD35- or Fc RIIB-containing stroma, splenic B
lymphocytes isolated from chimeric mice were analyzed by
FACS®. Again, as predicted for memory responses, an in-
crease in the frequency of NP-specific memory B lympho-
cytes was observed both in the BM and spleen after antigen
challenge in all chimeras (compare Fig. 2, b to d and c to
e). For example, the frequency of NP-specific memory B
lymphocytes in WT chimeras increased from a mean of 82  
12 to 420   92 per 106 cells in the BM and from 310   55
to 3,280   601 per 106 splenocytes. The relative frequency
of memory B lymphocytes was significantly reduced in the
BM (160   40/106 cells) and spleen (1,720   526/106
cells) of CD21/CD35-deficient chimeric mice. Consistent
with the reduced frequency of splenic ASCs, the relative
frequency of memory B lymphocytes was reduced in
spleens (1,560   526/106 cells) of Fc RIIB-deficient chi-
meric mice.
The finding of 10-fold differences in antibody produc-
tion between WT and Cr2 /  chimeras, but only two- to
threefold differences in memory B lymphocytes and ASC
frequencies, suggested that donor-derived memory B lym-
phocytes in Cr2 /  mice might be functionally unrespon-
sive. To address this question, serial adoptive transfers were
performed. Splenic B lymphocytes from primary recipient
mice were adoptively transferred along with antigen and T
cells into sublethally irradiated WT mice. 3 wk after trans-
fer, anti-NP titers and splenic ASC frequencies were deter-
mined. Consistent with earlier results, the mean anti-NP ti-
ter was approximately two- to threefold less in secondary
chimeric mice receiving primed B lymphocytes from Cr2 / 
primary chimeras compared with WT primary chimeras
(2,267   581 vs. 5,867   533, P   0.01; Fig. 4 a). Simi-
larly, analysis of the frequency of splenic ASCs revealed an
approximate twofold reduction in mice receiving primed B
lymphocytes from Cr2 /  versus WT primary chimeras (55  
18.2 vs. 94   7.4, P   0.07; Fig. 4 c). Thus, the frequency
of functional memory B lymphocytes was reduced in Cr2 / 
chimeras as evidenced by their failure to respond optimally
in WT recipients. The NP titer of recipients of primed B
lymphocytes from primary Fc RIIB /  donors was re-
duced by over fourfold relative to primary WT donors
(1,200   0 vs. 5,867   533). Moreover, even greater re-
duction was observed in the frequency of NP-specific
ASCs in secondary chimeras receiving B lymphocytes from
Fc RIIB /  primary chimeras (10.2   1.8, P   0.008; Fig.
4 c). Therefore, as observed in the spleens of primary
Fc RIIB /  chimeras, there was an impaired response after
secondary transfer into WT recipients.
Figure 4. Memory responses after secondary transfer. Splenic B lym-
phocytes from original chimeric mice were adoptively transferred intrave-
nously with KLH-primed T cells and NP-KLH into sublethally irradiated
WT (a and c) and Cr2 /  (b and d) recipients. 3 wk after secondary trans-
fer into WT (a) and Cr2 /  (b) mice, NP-binding serum IgG was mea-
sured by ELISA. Each symbol represents a single mouse. Horizontal bars
represent mean antibody titers. (c and d) ELISPOTs were performed on
recipient splenocytes to determine ASC frequency. Data are represented
as means   SEM from a single experiment. *, statistically significant differ-
ences. Statistical comparisons to WT chimeras were made (P   0.01).1195 Barrington et al.
An additional factor in the diminished recall response of
Cr2 /  chimeras is impaired antigen localization on chal-
lenge. To test this possibility, serial transfers were also per-
formed using Cr2 /  mice as secondary recipients. An
approximate twofold reduction in antibody titer was ob-
served in Cr2 /  versus WT recipients (1,067   133 vs.
2,533   353, P   0.03; Fig. 4 b). The difference in anti-
body titers between Cr2 /  secondary chimeras receiving
either splenocytes from WT or Cr2 /  primary chimeras
was again reflected at the level of ASC frequency (17   4.9
for Cr2 /  vs. 25.8   1.7 for WT; Fig. 4 d). Therefore, the
10-fold reduction in recall response of Cr2 /  chimeras
was due in large part to both a reduction in memory B
lymphocytes and a lack of complement receptors on recipi-
ent stroma.
Antigen Deposition in the Absence of CD21/CD35. To ex-
amine whether the ability to trap antigen efficiently con-
tributes to differences in recall responsiveness between chi-
meric mice, the groups of recipient mice were injected
with biotinylated NP-BSA 16 h before harvesting. Immu-
nohistochemical analyses of splenic sections from WT and
Fc RIIB /  chimeras identified antigen within PNA  GCs
(Fig. 5, a and b). By contrast, antigen deposition was negli-
gible within the GC of Cr2 /  chimeras (Fig. 5, c and d).
The lack of localized biotinylated antigen in Cr2 /  mice
was observed at multiple time points, ranging from 12–20 h
after administration, suggesting that kinetic differences in
antigen trapping are not responsible for the absence of de-
tectable antigen in Cr2 /  chimeras (unpublished data).
Importantly, antigen detected in WT and Fc RIIB /  chi-
meras colocalized with FDCs within the light zones of GCs
(unpublished data).
Discussion
The role of antigen in the maintenance of long-term B
lymphocyte memory is subject to debate. In this study, the
mechanism of antigen retention leading to long-term anti-
body production, persistence of memory B lymphocytes,
and affinity maturation was addressed using an adoptive
transfer model similar to that pioneered by Gray and Skar-
vall (9). Because memory responses using this model de-
pend on introduced antigen, it is amenable to examining
the contributions of receptors believed critical for capturing
and retaining antigen by adoptively transferring memory B
lymphocytes into mice deficient in either CD21/CD35 or
Fc RIIB. We demonstrated that CD21/CD35 expression
on radioresistant stomal cells (including FDCs) is important
for maintaining serum titers (Table I), high frequencies of
ASCs (Fig. 1) and memory B lymphocytes (Fig. 2), as well
as for optimal affinity maturation (Fig. 3, Table II). More-
over, recall responses were severely compromised in the
absence of CD21/CD35-bearing stroma (Figs. 1, c and d,
2, d and e, and 4; Table I). In contrast, although splenic re-
sponses were impaired in Fc RIIB /  chimeras, the ab-
sence of Fc RIIB on recipient cells did not affect overall
antibody persistence or frequency of BM ASCs and surpris-
ingly led to significantly increased serum affinity. These ob-
servations suggest that although both CD21/CD35 and
Fc RIIB participate in trapping antigen, overall memory B
lymphocyte responses are more dependent on stromal cell–
associated complement receptors.
Antigen-dependent maintenance of NP titers. The experi-
mental model used depends on antigen because WT mice
receiving memory B and T lymphocytes without antigen at
the time of cell transfer fail to sustain significant anti-NP ti-
ters. In addition, they are unable to mount significant recall
responses 16 wk after the transfer of memory B lympho-
cytes (Table I). These data suggest that memory B lympho-
cytes are not maintained (in the absence of antigen) to the
extent that they efficiently differentiate into antibody-pro-
ducing plasma cells after antigen challenge. Interestingly,
antibody titers in Cr2 /  chimeras were similar to WT chi-
meras not receiving antigen after 16 wk, suggesting that an-
tigen retention via CD21/CD35 is critical for antibody
persistence. However, chimeras lacking CD21/CD35 
stroma contained limited NP-specific ASCs. CD21/CD35
involvement in antibody persistence was examined previ-
ously, where it was reported that Cr2 /  mice immunized
with T-dependent antigens generated reduced antibody re-
sponses (29, 30). In one report, it was noted that the decay
of serum antibody after antigen challenge was faster in
Cr2 /  mice compared with WT mice (29), consistent
with the thesis that the ASC pool is not efficiently replen-
ished in the absence of CD21/CD35. However, because
these studies used Cr2 /  mice whose B lymphocytes and
Figure 5. Dependence on CD21/CD35  stroma for localizing antigen
in GCs. 16 wk after adoptive transfer of memory B lymphocytes, WT (a),
FcgRIIB /  (b), and Cr2 /  (c) chimeric mice were injected with biotin-
ylated NP-BSA. (d) WT chimeras not receiving biotinylated antigen. 5- M
splenic cryosections were stained with anti-IgM (blue) and PNA (green)
to delineate B lymphocyte zones and GCs, respectively. Arrows point
to detectable antigen, as visualized using SA-TRITC (red). Colocalized
IgM, PNA, and antigen are detected in white. Staining patterns shown
are representative of multiple sections ( 5) from five mice per chimeric
group.1196 B Lymphocyte Memory Dependency on Complement Receptors
follicular stroma lacked CD21/CD35, they were unable to
distinguish CD21/CD35-dependent antigen trapping from
its role as a B lymphocyte coreceptor. In this study, the re-
sponding memory B lymphocyte pool had intact B lym-
phocyte receptor signaling complexes and therefore the
contribution of stroma-derived CD21/CD35 for antigen
sequestration was isolated from coreceptor-associated B cell
receptor signaling. The implication of reduced antibody ti-
ters in Cr2 /  chimeras in this study is that CD21/CD35
on FDCs is critical in long-term antigen retention, al-
though other radioresistant CD21/CD35-expressing my-
eloid cells may also participate.
Differences in serum antibody levels in the various chi-
meric groups directly correlated with the frequency of NP-
specific ASCs in BM. ASC frequency is reduced in Cr2 / 
chimeras relative to WT chimeras, supporting the idea that
active ASC replacement contributes to effective long-term
B lymphocyte memory. Several recent reports addressed
the possibility of long-lived ASCs. One report using bro-
modeoxyuridine labeling concluded that 60% of BM ASCs
can survive in excess of 90 d without turnover (8). Another
study demonstrated that a fraction of adoptively transferred
ASCs continue to produce antibody for longer than 1 yr
(7). The interpretations of the latter study were questioned,
however, by another study using the same lymphocytic
choriomeningitis virus model antigen system that failed to
observe “antigen-independent long-lived persisting anti-
body” (28). Although experiments in this study did not ad-
dress ASC lifespan directly, the observation that WT chi-
meras not receiving antigen still produced measurable,
albeit significantly reduced, anti-NP titers is consistent with
the presence of low numbers of long-lived ASCs (negligi-
ble ASCs were detected in the BM).
Interestingly, differences in antibody titers between WT
chimeras and Cr2 /  chimeras was significant after 6–8 wk,
which suggests that either fewer long-lived ASCs are gen-
erated initially after transfer and/or that continued produc-
tion of ASCs is less efficient in mice without CD21/
CD35  stroma. Long-lived ASCs, as well as memory B
lymphocytes, are products of GC responses. Based on re-
sults using a Bcl-2 transgenic model, Smith et al. (31) pro-
posed that predominantly high affinity ASCs produced in
GCs are recruited to the BM. In the current model, the
observation of similar antibody titers after 2–3 wk suggests
that the initial GC responses between the chimeric groups
are comparable. The subsequent differences in antibody ti-
ters observed between WT and Cr2 /  chimeras after 6 wk
(i.e., after GC wane) could then be explained by less effi-
cient replenishment of the BM ASC pool.
Affinity Maturation. To delineate whether post-GC se-
lection contributed to altered antibody titers in WT and
Cr2 /   chimeras, relative serum affinity changes were
monitored. Early evaluation of affinity maturation demon-
strated that affinity increases with time after initial antigen
contact and that the degree of increase depends on the
amount of antigen encountered (11, 32, 33). Because affin-
ity increases with time, one presumes that either high affin-
ity ASCs are selectively surviving or that the production
and/or selection of new ASCs is ongoing (33, 34). Long-
lived ASCs possess little to no surface Ig and are not re-
sponsive to antigen. Therefore, they are unlikely subject to
selection (8, 24, 35, 36). In light of the data presented here,
it appears that post-GC selection establishes new ASCs im-
portant for increases in relative serum affinity. Relative se-
rum affinity was measured in this study using two indepen-
dent assays. Previous work using the ELISA-based assay
demonstrated that affinity measurements correlated with
mutations within VDJ genes conferring high affinity bind-
ing (37, 38). Both techniques showed that over the course
of 16 wk relative serum affinity increased modestly in WT
chimeras whereas no statistically significant increase was
observed in Cr2 /  chimeras (Fig. 3, Table II). Therefore,
our results imply that antigen deposition via CD21/CD35
is important for post-GC selection, a thesis supported by
the observation that Cr2 /  chimeras were less able to trap
injected antigen (Fig. 5 c). Previous work using LT -defi-
cient mice concluded that FDCs are not required for affin-
ity maturation (39). However, differences between these
results versus those of this study are likely explained by the
immunization protocols. Matsumoto et al. (39) immunized
with much larger and more frequent doses of antigen in ad-
dition to using adjuvant, likely diminishing the importance
of antigen deposition on FDCs for affinity maturation.
Memory B Lymphocyte Persistence. The longevity of mem-
ory B lymphocytes is proposed as antigen independent
based on an experimental system in which the antigen
specificity was switched (40). Additional support for anti-
gen-independent persistence of memory B lymphocytes
comes from reports that memory B lymphocytes are gen-
erally resting cells without measurable cell proliferation
(41). Moreover, they persist in the absence of T cell help
(42, 43) or chemokines and chemokine receptors required
for FDC development (10, 39). In this study, the fre-
quency of memory B lymphocytes is reduced significantly
in WT chimeras not receiving antigen, although low fre-
quencies were detectable predominantly in the spleen (Fig.
2 c). These memory B lymphocytes were donor derived
because they were identified using an allo-specific marker
and in addition, because irradiated control mice contained
a negligible number of memory B lymphocytes. These
data are consistent with reports suggesting that at least a
fraction of the memory B lymphocyte pool is maintained
in the absence of antigen. However, significantly more
memory B lymphocytes were detected in WT chimeras
receiving antigen, suggesting that a substantial fraction of
the memory B lymphocyte pool is replenished with time.
These frequencies of memory B lymphocytes detected by
FACS® are similar to frequencies reported by Takahashi et
al. (44). Similar to differences found with ASCs, optimal
memory B lymphocyte frequency depended on stroma-
derived CD21/CD35, a finding that was supported by
three independent observations (Figs. 2 and 4). The consis-
tent reductions in both ASC and memory B lymphocyte
frequency observed between WT and Cr2 /  chimeras
with and without antigen, in concert with changes in rela-
tive serum affinities, suggest that clonal selection continues1197 Barrington et al.
after GC wane. Thus, it is suggested that both antigen-
dependent and antigen-independent mechanisms drive B
lymphocyte memory.
Role of Stroma-derived Fc RIIB. The importance of Fc -
RIIB expression on stroma was investigated by comparing
memory responses in Fc RIIB /  chimeras to WT chime-
ras. It was previously demonstrated that secondary re-
sponses in Fc RIIB /  mice, as well as in Fc c
 /  mice
(45), were normal (23). However, because these mice lack
Fc RIIB on B lymphocytes and FDCs, these studies were
unable to distinguish their relative contributions to the im-
mune response. Fc RIIB is inducible on FDCs (22), mak-
ing it a candidate for long-term retention of antigen via
IgG immune complexes. Myeloid cells (including mac-
rophages, monocytes, neutrophils, and mast cells) also ex-
press Fc RIIB along with Fc RI and RIII, and it is there-
fore possible that other radioresistant cells contribute to
long-term antigen retention in the current system (46). An-
tibody persistence appears independent of Fc RIIB on
FDCs because WT and Fc RIIB /  chimeras had similar
antibody titers and BM ASCs. However, both splenic ASC
and memory B lymphocyte frequency were reduced in
Fc RIIB /  chimeras, suggesting either that antigen depo-
sition via Fc RIIB is required for post-GC production of
both splenic populations or that selection is more stringent
in the absence of Fc RIIB (Figs. 1 and 2). Measurements
of relative serum affinity seem to favor the latter hypothe-
sis because affinity increases dramatically with time in
Fc RIIB /  chimeras (Fig. 3, Table II). One explanation is
that selective pressure might be greater in Fc RIIB /  chi-
meras due to increased negative signaling on B lympho-
cytes by unoccupied Fc  portions of immune complexes
not bound by Fc RIIB on FDCs. This possibility is based
on the assumption that Fc RIIB on FDCs compete with
Fc RIIB on B lymphocytes for binding IgG. Interestingly,
Fc RIIB /  chimeras are also similar to WT chimeras in
their ability to trap injected antigen (Fig. 5 b). This might
be due to increased trapping of antigen via CD21/CD35,
although we did not directly address this possibility. An al-
ternative hypothesis is that Fc RIIB has a signaling role on
splenic FDCs that enhances the release of chemokines for
retention of memory B lymphocytes and ASCs. FDCs are a
source of at least one such chemokine, B lymphocyte
chemokine-1, which promotes the localization of B lym-
phocytes within the splenic follicles (47, 48).
Recall Responses. B lymphocyte memory is best assessed
functionally by measuring the recall response. Similar to
findings of Gray and Skarvall (9), efficient recall responses
in this study require antigen at the time of adoptive trans-
fer. Despite detectable donor-derived memory B lympho-
cytes in WT chimeras deprived of antigen, these mice did
not generate a significant recall antibody response (Table I).
Significantly, Cr2 /  chimeras demonstrated only a two-
fold increase in antibody titer after challenge whereas titers
in WT and Fc RIIB /  chimeras increased 8–10-fold.
Therefore, the recall response was impaired in the absence
of CD21/CD35-bearing stroma. This result was addition-
ally substantiated by secondary transfer of splenocytes from
WT and Cr2 /  chimeras into WT secondary chimeras
(Fig. 4, a and c). It is likely that several factors contributed
to diminished recall responses in Cr2 /  chimeras. They
had reduced serum antibody titers that potentially contrib-
uted to less efficient antigen trapping, as well as lower fre-
quencies of memory B lymphocytes, necessary to mount a
recall response. Interestingly, only two- to threefold reduc-
tions in ASCs and memory B lymphocytes were observed
in Cr2 /  chimeras compared with WT chimeras, yet 10-
fold differences in antibody titers were observed. This sug-
gested that memory B lymphocytes in Cr2 /  chimeras
were less responsive compared with those in WT chimeras
due to less efficient trapping of antigen. This possibility
seems likely because memory B lymphocytes from WT
mice respond less efficiently after transfer into Cr2 /  re-
cipients. Thus, the combined effects of fewer memory B
lymphocytes and less efficient response in the absence of
CD21/CD35 would explain the overall 10-fold reduction
in antibody titers in Cr2 /  chimeras. Also intriguing is
that despite a near normal antibody response in the
Fc RIIB /  chimeras, the frequency of splenic ASCs was
significantly reduced both in the primary (Fig. 1 b) and sec-
ondary chimeras (Fig. 4 b). Thus, as discussed above, Fc -
RIIB seems to be required for the maintenance of memory
B lymphocytes in the spleen independent of the amount of
antigen trapping (Fig. 5 b).
In conclusion, the data presented here support a model
whereby humoral memory is maintained by continuous
antigen-dependent selection and/or differentiation of
memory B lymphocytes and ASCs. Fc RIIB on splenic
FDCs (or on radioresistant myeloid cells) also appears im-
portant for the maintenance of splenic memory B lym-
phocytes but is not required for overall memory recall re-
sponses. The implication from Cr2 /  chimeras is that
ongoing clonal selection depends on antigen retained
long-term on CD21/CD35-bearing FDCs. Lastly, the
availability of CD21/CD35-bearing stroma provides the
appropriate microenvironment for generating substantial
recall responses.
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